139 related articles for article (PubMed ID: 18191511)
1. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
Dadashzadeh S; Vali AM; Rezaie M
Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
[TBL] [Abstract][Full Text] [Related]
2. Optimization of liposomal topotecan for use in treating neuroblastoma.
Chernov L; Deyell RJ; Anantha M; Dos Santos N; Gilabert-Oriol R; Bally MB
Cancer Med; 2017 Jun; 6(6):1240-1254. PubMed ID: 28544814
[TBL] [Abstract][Full Text] [Related]
3. Dose-Dependent Production of Anti-PEG IgM after Intramuscular PEGylated-Hydrogenated Soy Phosphatidylcholine Liposomes, but Not Lipid Nanoparticle Formulations of DNA, Correlates with the Plasma Clearance of PEGylated Liposomal Doxorubicin in Rats.
Subasic CN; Butcher NJ; Minchin RF; Kaminskas LM
Mol Pharm; 2023 Jul; 20(7):3494-3504. PubMed ID: 37256791
[TBL] [Abstract][Full Text] [Related]
4. pH-sensitive liposomes bearing a chemotherapeutic agent and a natural apoptosis modulator for effective intracellular delivery to the solid tumor.
Saraf S; Jain SK
Drug Deliv Transl Res; 2023 Dec; 13(12):2961-2981. PubMed ID: 37306925
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamic evaluation of hyaluronic acid-modified imatinib-loaded PEGylated liposomes in CD44-positive Gist882 tumor-bearing mice.
Huang J; Chen J
J Liposome Res; 2024 Mar; 34(1):97-112. PubMed ID: 37401372
[TBL] [Abstract][Full Text] [Related]
6. Cerasome Versus Liposome: A Comparative Pharmacokinetic Analysis Following Intravenous Administration into Rats.
Bahri S; Abdollahizad E; Mahlooji I; Rezaee E; Abbasian Z; Dadashzadeh S
Iran J Pharm Res; 2023; 22(1):e138362. PubMed ID: 38444706
[TBL] [Abstract][Full Text] [Related]
7. Preparation, characterization and wound-healing effect of PEGylated nanoliposomes loaded with oleuropein.
Alquraishi R; Al-Samydai A; Al Azzam KM; Alqaraleh M; Al-Halaseh L; Sanabrah A; Abu Hajleh MN; Al Khatib A; Alsaher W; Negim ES; Khleifat K
Biomed Chromatogr; 2023 Nov; 37(11):e5716. PubMed ID: 37580869
[TBL] [Abstract][Full Text] [Related]
8. Manufacturing drug co-loaded liposomal formulations targeting breast cancer: Influence of preparative method on liposomes characteristics and in vitro toxicity.
Gkionis L; Campbell RA; Aojula H; Harris LK; Tirella A
Int J Pharm; 2020 Nov; 590():119926. PubMed ID: 33010397
[TBL] [Abstract][Full Text] [Related]
9. Conventional vs PEGylated loaded liposomal formulations by microfluidics for delivering hydrophilic chemotherapy.
Jaradat E; Meziane A; Lamprou DA
Int J Pharm; 2024 Apr; 655():124077. PubMed ID: 38569975
[TBL] [Abstract][Full Text] [Related]
10. Quantification of Unencapsulated Drug in Target Tissues Demonstrates Pharmacological Properties and Therapeutic Effects of Liposomal Topotecan (FF-10850).
Kimura T; Okada K; Morohashi Y; Kato Y; Mori M; Kato H; Matsumoto T; Shimoyama S
Pharm Res; 2024 Apr; 41(4):795-806. PubMed ID: 38536615
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Characterization of Paclitaxel-Loaded PEGylated Liposomes by the Microfluidics Method.
Jaradat E; Weaver E; Meziane A; Lamprou DA
Mol Pharm; 2023 Dec; 20(12):6184-6196. PubMed ID: 37931072
[TBL] [Abstract][Full Text] [Related]
12. Preparation, Characterization, and Anticancer Activity of PEGylated Nano Liposomal Loaded with Rutin against Human Carcinoma Cells (HT-29).
Al-Ekaid NM; Al-Samydai A; Al-Deeb I; Nsairat H; Khleifat K; Alshaer W
Chem Biodivers; 2023 Nov; 20(11):e202301167. PubMed ID: 37781742
[TBL] [Abstract][Full Text] [Related]
13. Pegylated liposome encapsulating docetaxel using microfluidic mixing technique: Process optimization and results in breast cancer models.
Dacos M; Immordino B; Diroff E; Sicard G; Kosta A; Rodallec A; Giacometti S; Ciccolini J; Fanciullino R
Int J Pharm; 2024 May; 656():124091. PubMed ID: 38588758
[TBL] [Abstract][Full Text] [Related]
14. In vitro co-delivery of 5-fluorouracil and all-trans retinoic acid by PEGylated liposomes for colorectal cancer treatment.
Azarifar Z; Amini R; Tanzadehpanah H; Afshar S; Najafi R
Mol Biol Rep; 2023 Dec; 50(12):10047-10059. PubMed ID: 37902908
[TBL] [Abstract][Full Text] [Related]
15. The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.
Fugit KD; Anderson BD
J Control Release; 2014 Jan; 174():88-97. PubMed ID: 24231406
[TBL] [Abstract][Full Text] [Related]
16. [Preparation and Characterization of Clopidogrel Bisulfate Liposomes].
Wu BQ; He YJ; Yin ZN; Zhang ZR; Deng L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 52(4):630-636. PubMed ID: 34323042
[TBL] [Abstract][Full Text] [Related]
17. QbD Enabled Development and Evaluation of Pazopanib Loaded Nanoliposomes for PDAC Treatment.
Shinde A; Panchal K; Patra P; Singh S; Enakolla S; Paliwal R; Chaurasiya A
AAPS PharmSciTech; 2024 May; 25(5):97. PubMed ID: 38710894
[TBL] [Abstract][Full Text] [Related]
18. High throughput microfluidics-based synthesis of PEGylated liposomes for precise size control and efficient drug encapsulation.
Akar S; Fardindoost S; Hoorfar M
Colloids Surf B Biointerfaces; 2024 Jun; 238():113926. PubMed ID: 38677154
[TBL] [Abstract][Full Text] [Related]
19. Dose-Dependent Effect of Phenothiazines as Dynamin II Inhibitors on the Uptake of PEGylated Liposomes by Endocytic Cells and In Vivo Pharmacokinetics of PEGylated Liposomal Doxorubicin in Rats.
Subasic CN; Butcher NJ; Simpson F; Minchin RF; Kaminskas LM
Mol Pharm; 2023 Sep; 20(9):4468-4477. PubMed ID: 37548597
[TBL] [Abstract][Full Text] [Related]
20. Fabrication, optimization, and characterization of pH-responsive PEGylated nanoniosomes containing gingerol for enhanced treatment of breast cancer.
Asghari Lalami Z; Tafvizi F; Naseh V; Salehipour M
Naunyn Schmiedebergs Arch Pharmacol; 2023 Dec; 396(12):3867-3886. PubMed ID: 37368028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]